User: Guest  Login
Title:

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.

Document type:
Article; Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Andlauer, Till F M; Link, Jenny; Martin, Dorothea; Ryner, Malin; Hermanrud, Christina; Grummel, Verena; Auer, Michael; Hegen, Harald; Aly, Lilian; Gasperi, Christiane; Knier, Benjamin; Müller-Myhsok, Bertram; Jensen, Poul Erik Hyldgaard; Sellebjerg, Finn; Kockum, Ingrid; Olsson, Tomas; Pallardy, Marc; Spindeldreher, Sebastian; Deisenhammer, Florian; Fogdell-Hahn, Anna; Hemmer, Bernhard
Abstract:
BACKGROUND: Upon treatment with biopharmaceuticals, the immune system may produce anti-drug antibodies (ADA) that inhibit the therapy. Up to 40% of multiple sclerosis patients treated with interferon β (IFNβ) develop ADA, for which a genetic predisposition exists. Here, we present a genome-wide association study on ADA and predict the occurrence of antibodies in multiple sclerosis patients treated with different interferon β preparations. METHODS: We analyzed a large sample of 2757 genotyped and...     »
Journal title abbreviation:
BMC Med
Year:
2020
Journal volume:
18
Journal issue:
1
Fulltext / DOI:
doi:10.1186/s12916-020-01769-6
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/33143745
Print-ISSN:
1741-7015
TUM Institution:
Molekulare Immunologie (Prof. Knolle); Neurologische Klinik und Poliklinik
 BibTeX